Nasal vaccination with attenuated Salmonella expressing VapA: TLR2 activation is not essential for protection against R. equi infection

Highlights • Administration of attenuated Salmonella harbouring the VapA antigen (STM VapA+) via nasal route induced a protective immune response. • STM VapA+ protects TLR2-KO and TLR4-deficient mice against R. equi challenge. • STM VapA+ stimulates antigen-specific CD4+ T cells without the particip...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine Vol. 31; no. 41; pp. 4528 - 4535
Main Authors: Cardoso, Silvia Almeida, Oliveira, Aline Ferreira, Ruas, Luciana Pereira, Trevisani, Marcel Montels, De Oliveira, Leandro Licursi, Hanna, Ebert Seixas, Roque-Barreira, Maria Cristina, Soares, Sandro Gomes
Format: Journal Article
Language:English
Published: Kidlington Elsevier Ltd 23-09-2013
Elsevier
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Administration of attenuated Salmonella harbouring the VapA antigen (STM VapA+) via nasal route induced a protective immune response. • STM VapA+ protects TLR2-KO and TLR4-deficient mice against R. equi challenge. • STM VapA+ stimulates antigen-specific CD4+ T cells without the participation of TLR2. • TLR2 is required for immune response recall in a mouse model.
Bibliography:http://dx.doi.org/10.1016/j.vaccine.2013.07.067
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2013.07.067